Corient Private Wealth’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,000
| Closed | -$2.76K | – | 2467 |
|
|
2024
Q4 | $2.76K | Hold |
12,000
| – | – | ﹤0.01% | 2329 |
|
|
2024
Q3 | $25.8K | Hold |
12,000
| – | – | ﹤0.01% | 2380 |
|
|
2024
Q2 | $61.9K | Hold |
12,000
| – | – | ﹤0.01% | 2239 |
|
|
2024
Q1 | $64.2K | Hold |
12,000
| – | – | ﹤0.01% | 2210 |
|
|
2023
Q4 | $93.5K | Sell |
12,000
-14,666
| -55% | -$114K | ﹤0.01% | 2160 |
|
|
2023
Q3 | $105K | Hold |
26,666
| – | – | ﹤0.01% | 2012 |
|
|
2023
Q2 | $84K | Hold |
26,666
| – | – | ﹤0.01% | 1973 |
|
|
2023
Q1 | $71.2K | Buy |
+26,666
| New | +$71.2K | ﹤0.01% | 1902 |
|